ARCHIVES

QOL With Femara Comparable To Placebo, Analysis Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

Abraxane and Gemcitabine Improves Overall Survival

November 30, 2012

In Brief: Koprowski, Niederhuber, Engstrom Chair DCE, DCT, DCPC BSCs; Roentgen Ray Officers Named

June 19, 1987

Also In sudden policy change, NIH proposes one-year ban on consulting by employees.

October 1, 2004

Bladder Cancer Survival Rate Rises With Neoadjuvant Chemo

September 26, 2003

In Brief: ONS Invites Proposals For Research On Hazards Of Chemotherapy; UTSCC Adopts Code Of Ethics

August 31, 1984

Abstracts Of ‘Most Newsworthy’ Papers

June 10, 1977